Ivana Vaněčkova (Ivana Vaněčková)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Oxidative Stress

Cardiovascular Risk Factors

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Silvie Hojná, Zoe Kotsaridou, Zdeňka Vaňourková, Hana Rauchová, Michal Behuliak, Petr Kujal, Michaela Kadlecová, Josef Zicha, Ivana Vaněčkova
Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease. Biomedicines 10 (10) (2022)
Hana Malinska, Martina Hüttl, Irena Markova, Denisa Miklánková, Silvie Hojná, František Papoušek, Jan Šilhavý, Petr Mlejnek, Josef Zicha, Jaroslav Hrdlička, Michal Pravenec, Ivana Vaněčkova
Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein. Biomedicines 10 (9) (2022)
Martina Hüttl, Irena Markova, Denisa Miklankova, Iveta Zapletalová, Martin Poruba, Martin Haluzík, Ivana Vaněčkova, Hana Malinska
In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia. International journal of molecular sciences 22 (21) (2021)